Audrey Fedyszyn Jakubowski Lazarus

Dear Family, Friends and Colleagues

It is my very sad duty to announce the death of my beloved wife, Audrey, Fedyszyn Jakubowski Lazarus on September 8, 2025, from the corticobasal variant of Frontotemporal Degeneration. Her clinical course lasted 11 years and she died peacefully. There will be no immediate memorial service because Audrey willed her brain to medical research.

I am including a proclamation from her beloved College at Seton Hill University, Greensburg Pennsylvania, that describes her amazing career, to become a senior executive in the pharmaceutical industry (see attachment).

What is missing in the description of her professional accomplishment’s, is her beautiful loving life devoted to her 2 children, Lara and Alex and 2 natural grandchildren Natalie and Ethan and 4 stepchildren Mark, Elyse, Lynne and Laura and 8 Lazarus grandchildren.

I have been blessed to love Audrey for 37 years. She was my total partner, my administrative coach, confidant, and supporter. Her, patience, grace, ability, flexibility and competence are exemplified by the following anecdote.

When we lived in China for 3 years between 1999 and 2002, she became the darling of the communist party and was asked to help quantify patient satisfaction. She was not asked to continue in this position for long; she reported real problems. Because of her abilities, she cotaught the evidence-based medicine course using doctoral training methods including problem solving, minimal lecturing, daunting group competition and team building all in English. I told her she was asking too much. Her response to me was, not exactly, mind your own business. At the conclusion of the course the most select medical students in China presented her with a scroll announcing she was the best teacher they EVER HAD. At the same time, she taught Chinese nurses, volunteered for the major English language Chinese medical journal to help translate Chinglish into English, and was a star pupil in her Chinese cooking class and functioned as a VP for regulatory affairs at a US biomedical startup

I am bereft and my heart is breaking; I know she is irreplaceable.

Gerald Lazarus, MD

PLEASE REVIEW ATTACHMENT